THQ News and Press, Tekla Healthcare Opportunies Fund Shares of Beneficial Interest From 04/27/22

HQL pays regular quarterly dividends with a close to double digit yield, and despite poor price growth over medium and long run, HQL’s total return is impressive. In the past three months, a dividend cut and extension of buyback period played a significant role in price movemen...

There’s nothing we closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount (of course!), plus a much bigger dividend, because yields and prices move in opposite directions. In fact, with CEFs, we...

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promise high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad market...

Yields up to 7% and dividends you don't want to miss. The market is selling off these funds, I'm buying them up. You can buy them too. Let's talk about why you should. For further details see: 2 Crashing Funds That I'm Buying Today

Warren Buffett once listed the only 3 ways that a smart person can go broke. We zero in on one of those reasons to explain why it is so dangerous for investors. We then make the connection to why we don't buy CEFs. For further details see: Buffett Warns Of How Smart Peop...

THQ’s stock selection and level of balance in its portfolio is impressive. THQ pays steady monthly dividend with an average yield of 7 percent. Banking on growth prospects of the overall healthcare sector, THQ is well diversified in order to generate steady growth rate over...

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promise high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad market...

BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...

Tekla Healthcare Opportunities Fund (NYSE:THQ) had declared $0.1125/share monthly dividend, in line with previous. Payable Feb. 28; for shareholders of record Feb. 18; ex-div Feb. 17. See THQ Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Hea...

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...